Stable vitiligo treated by a combination of low-dose oral pulse betamethasone and autologous, noncultured melanocyte-keratinocyte cell transplantation

Dermatologic Surgery

Volumn 32, Issue 4, 2006, Pages 536-541

  Mulekar, Sanjeev V ^a  

^a National Center for Vitiligo and Psoriasis   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; MIDAZOLAM; PENTAZOCINE;

ACNE; ADOLESCENT; ADULT; ARTICLE; CELL TRANSPLANTATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG PULSE THERAPY; FEMALE; HUMAN; KERATINOCYTE; LOW DRUG DOSE; MALE; MELANOCYTE; PRIORITY JOURNAL; SIDE EFFECT; SKIN BIOPSY; SKIN PIGMENTATION; VITILIGO; WEIGHT GAIN; WOUND INFECTION;

ADOLESCENT; ADULT; BETAMETHASONE; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; GLUCOCORTICOIDS; HUMANS; KERATINOCYTES; MALE; MELANOCYTES; MIDDLE AGED; PULSE THERAPY, DRUG; TREATMENT OUTCOME; VITILIGO;

EID: 33646047123     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2006.32109.x     Document Type: Article

References (16)

1. Kovacs SO. CME vitiligo. J Am Acad Dermatol 1998 38 647 6.
2. Naughton GK Eisinger M Brystryn JC. Detection of antibodies to melanocytes by specific immunoprecipitation. J Invest Dermatol 1983 81 540 2.
3. Njoo MD Spuls PI Bos JD et al. Non surgical repigmentation therapies in vitiligo. Meta-analysis of the literature. Arch Dermatol 1998 134 1532 40.
4. Spencer JM Nossa R Ajmeri J. Treatment of vitiligo with the 308-nm excimer laser a pilot study. J Am Acad Dermatol 2002 46 127 31.
5. Baltas E Cosma Z Ignacz F et al. Treatment of vitiligo with the 308-nm xenon chloride excimer laser. Arch Dermatol 2002 138 1619 20.
6. Pasricha JS Khaitan B. Oral mini pulse therapy with betamethasone in vitiligo patients having extensive or fast spreading disease. Int J Dermatol 1993 32 753 7.
7. Radakovic-Fijan S Furnsinn-Friedl AM Honigsmann H et al. Oral dexamethasone pulse treatment for vitiligo. J Am Acad Dermatol 2001 44 814 7.
8. Njoo MD Westerhoff W Bos JD et al. A systematic review of autologous transplantation methods in vitiligo. Arch Dermatol 1998 134 1543 9.
9. Yaar M Gilchrest BA. Vitiligo the evolution of cultured epidermal autografts and other surgical treatment modalities. Arch Dermatol 2001 137 348 9.
10. Mulekar SV. Melanocyte-keratinocyte cell transplantation for stable vitiligo. Int J Dermatol 2003 42 132 6.
11. Juhlin L. How unstable is the concept of stability in surgical repigmentation of vitiligo. Dermatology 2000 201 183.
12. Mulekar SV. Long-term follow-up study of segmental and focal vitiligo treated by autologous, noncultured melanocyte-keratinocyte cell transplantation. Arch Dermatol 2004 140 1211 5.
13. Le Poole IC Wankowicz-Kalinska A Van den Wijngaard RMJGJ et al. Autoimmune aspects of depigmentation in vitiligo. J Investig Dermatol Symp Proc 2004 9 68 72.
14. Hann SK Lee HJ. Segmental vitiligo clinical findings in 208 patients. J Am Acad Dermatol 1996 35 671 4.
15. Reid IR. Time to end steroid induced fractures. Arch Dermatol 2001 137 493 4.
16. Van Staa TP Leufkens HG Cooper C. The epidemiology of corticosteroid induced osteoporosis a meta-analysis. Osteoporosis Int 2002 13 777 87.